HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Type III Properdin Deficiency
Also Known As:
Properdin Deficiency, Type III
Networked:
1
relevant articles (
0
outcomes,
0
trials/studies)
Disease Context: Research Results
Congenital, Hereditary, and Neonatal Diseases and Abnormalities: 933
Inborn Genetic Diseases: 11939
Primary Immunodeficiency Diseases: 1189
Hereditary Complement Deficiency Diseases: 254
Type III Properdin Deficiency: 1
X-Linked Genetic Diseases: 42
Type III Properdin Deficiency: 1
Immune System Diseases: 4321
Immunologic Deficiency Syndromes: 91
Primary Immunodeficiency Diseases: 1189
Hereditary Complement Deficiency Diseases: 254
Type III Properdin Deficiency: 1
Amino Acids, Peptides, and Proteins: 1
Proteins: 484843
Blood Proteins: 12459
Serum Globulins: 553
Beta-Globulins: 159
Properdin: 476
Type III Properdin Deficiency: 1
Immunoproteins: 43
Complement System Proteins: 33379
Properdin: 476
Type III Properdin Deficiency: 1
Globulins: 3062
Serum Globulins: 553
Beta-Globulins: 159
Properdin: 476
Type III Properdin Deficiency: 1
Drugs and Biologics
Drugs and Important Biological Agents (IBA) related to Type III Properdin Deficiency:
1.
Tyrosine (L-Tyrosine)
FDA Link
10/15/1996 - "
Molecular characterization of properdin deficiency type III: dysfunction produced by a single point mutation in exon 9 of the structural gene causing a tyrosine to aspartic acid interchange.
"
2.
Aspartic Acid (Aspartate)
FDA Link
10/15/1996 - "
Molecular characterization of properdin deficiency type III: dysfunction produced by a single point mutation in exon 9 of the structural gene causing a tyrosine to aspartic acid interchange.
"